Oct. 18, 2022 – The Centers for Medicare & Medicaid Services (CMS) is beginning to establish a framework for the Medicare drug pricing negotiations mandated in the recently enacted Inflation Reduction Act (IRA), a process that will be complicated and controversial. “Passage of the Inflation Reduction Act – including provisions to mandate Medicare negotiations on […]
Read more
July 27, 2020 – The four Executive Orders signed by President Trump on Friday were designed to address drug pricing concerns, but their combined impact is modest and they are “unlikely to have any immediate effect,” according to Coalition for Healthcare Communication Executive Director Jon Bigelow. However, they do “give the president talking points for […]
Read more